Angiotensin-II-receptor antagonists (sartans) Article 31 referral - CHMP assessment report
Pharmazeutisch
Angiotensin-II-receptor antagonists (sartans) Article 31 referral - CHMP assessment report
Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.
Dosierung
Angiotensin-II-receptor antagonists (sartans) Article 31 referral - CHMP assessment report
Stärke
Angiotensin-II-receptor antagonists (sartans) Article 31 referral - CHMP assessment report
Packungsgröße
Angiotensin-II-receptor antagonists (sartans) Article 31 referral - CHMP assessment report
Form
Angiotensin-II-receptor antagonists (sartans) Article 31 referral - CHMP assessment report
Quelle
European Medicines Agency
Sicherheitsprofil
Kontraindikationen
Angiotensin-II-receptor antagonists (sartans) Article 31 referral - CHMP assessment report
Nebenwirkungen
Angiotensin-II-receptor antagonists (sartans) Article 31 referral - CHMP assessment report
